| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Neuroendocrine Unit, Charles A. Dana Research Institute, Beth Israel Hospital, and the Department of Neurology, Harvard Medical School, Boston, MA.
Presented in part at the 118th annual meeting of the American Neurological Association, October 19, 1993.
Received November 15, 1994. Accepted in final form January 28, 1995.
Address correspondence and reprint requests to Dr. Andrew G. Herzog, Neuroendocrine Unit, Beth Israel Hospital, 330 Brookline Avenue, Boston, MA 02215.
This open trial assessed the effects of adjunctive progesterone therapy on seizure frequency in 25 women with catamenial exacerbation of complex partial (CPS) and secondary generalized motor (SGMS) seizures.Progesterone was well tolerated by 23 of the 25 women and had readily reversible dose-related side effects of asthenia and emotional depression in two. Eighteen women (72%) experienced a decline in seizure frequency during a 3-month treatment period compared with the 3 months prior to therapy (p less than 0.01). Average daily CPS frequency declined by 54% (p less than 0.01), SGMS by 58% (p less than 0.02).
NEUROLOGY 1995;45: 1660-1662
This article has been cited by other articles:
|
|
 |
|
  K. Vagnerova, I. P. Koerner, and P. D. Hurn Gender and the Injured Brain Anesth. Analg., July 1, 2008; 107(1): 201 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Veliskova Estrogens and Epilepsy: Why Are We So Excited? Neuroscientist, February 1, 2007; 13(1): 77 - 88. [Abstract] [PDF]
|
|
|
|
 |
|
 A. G. Herzog Menstrual disorders in women with epilepsy Neurology, March 28, 2006; 66(66_suppl_3): S23 - S28. [Abstract] [Full Text]
|
|
|
|
|
|
V. Erden, Z. Yangin, K. Erkalp, H. Delatioglu, F. Bahceci, and A. Seyhan Increased Progesterone Production During the Luteal Phase of Menstruation May Decrease Anesthetic Requirement Anesth. Analg., October 1, 2005; 101(4): 1007 - 1011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Foldvary-Schaefer and T. Falcone Catamenial epilepsy: Pathophysiology, diagnosis, and management Neurology, September 1, 2003; 61(90062): S2 - 15. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. Liporace and A. D'Abreu Epilepsy and Women's Health: Family Planning, Bone Health, Menopause, and Menstrual-Related Seizures Mayo Clin. Proc., April 1, 2003; 78(4): 497 - 506. [Abstract] [PDF]
|
|
|
|
 |
|
 S. J. Murphy, R. J. Traystman, P. D. Hurn, and S. P. Duckles Progesterone Exacerbates Striatal Stroke Injury in Progesterone-Deficient Female Animals Editorial Comment Stroke, May 1, 2000; 31(5): 1173 - 1178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. G. Herzog Progesterone therapy in women with epilepsy: A 3-year follow-up Neurology, June 1, 1999; 52(9): 1917 - 1917. [Full Text]
|
|
|
|
 |
|
 A. G. Herzog Psychoneuroendocrine Aspects of Temporolimbic Epilepsy: Part II: Epilepsy and Reproductive Steroids Psychosomatics, April 1, 1999; 40(2): 102 - 108. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. G. Kokate, M. K. Banks, T. Magee, S.-I. Yamaguchi, and M. A. Rogawski Finasteride, a 5alpha -Reductase Inhibitor, Blocks the Anticonvulsant Activity of Progesterone in Mice J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 679 - 684. [Abstract] [Full Text]
|
|
|
|
|
|
T. G. Kokate, S.-I. Yamaguchi, L. K. Pannell, U. Rajamani, D. M. Carroll, A. B. Grossman, and M. A. Rogawski Lack of Anticonvulsant Tolerance to the Neuroactive Steroid Pregnanolone in Mice J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 553 - 558. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Concas, M. C. Mostallino, P. Porcu, P. Follesa, M. L. Barbaccia, M. Trabucchi, R. H. Purdy, P. Grisenti, and G. Biggio Role of brain allopregnanolone in the plasticity of gamma -aminobutyric acid type A receptor in rat brain during pregnancy and after delivery PNAS, October 27, 1998; 95(22): 13284 - 13289. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
